Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
AstraZeneca
University of California, San Francisco
University of Nebraska
Nagoya University
Fox Chase Cancer Center
Dana-Farber Cancer Institute